Treatment of Helicobacter pylori and prevention of gastric cancer

Journal of Digestive Diseases

Volumn 9, Issue 1, 2008, Pages 8-13

  Cheung, Ting Kin ^a   Wong, Benjamin C Y ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric cancer; Helicobacter pylori; Prevention

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ASCORBIC ACID; BETA CAROTENE; CLARITHROMYCIN; CLAVULANATE POTASSIUM; GARLIC EXTRACT; GARLIC OIL; METRONIDAZOLE; OMEPRAZOLE; PLACEBO; SELENIUM;

ATROPHIC GASTRITIS; CANCER GROWTH; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CHINA; CLINICAL PROTOCOL; CLINICAL TRIAL; DISEASE MODEL; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PATHOGENESIS; PRECANCER; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RISK FACTORS; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 38849197537     PISSN: 17512972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2007.00315.x     Document Type: Review

References (60)

1. Parkin DM. International variation. Oncogene 2004; 23: 6329-40.
2. Pisani P, Bray F, Parkin DM. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer 2002; 97: 72-81.
3. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis. Am J Gastroenterol 1999; 94: 2373-9.
4. Limburg P, Qiao Y, Mark S et.al. Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. J Natl Cancer Inst 2001; 93: 226-33.
5. El-Omar EM, Oien K, Murray LS et.al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: Critical role of H. pylori. Gastroenterology 2000; 118: 22-30.
6. Uemura N, Okamoto S, Yamamoto S et.al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
7. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
8. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115: 642-8.
9. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-9.
10. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000; 118: 31-5.
11. Chang YW, Han YS, Lee DK et.al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002; 101: 469-74.
12. Correa P. Human gastric carcinogenesis: A multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52: 6735-40.
13. Schorah CJ, Sobala GM, Sanderson M, Collis N, Primrose JN. Gastric juice ascorbic acid: Effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr 1991; 53: 287S-293S.
14. Banerjee S, Hawksby C, Miller S, Dahill S, Beattie AD, McColl KE. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317-22.
15. Zhang ZW, Patchett SE, Perrett D, Domizio P, Farthing MJ. Gastric alpha-tocopherol and beta-carotene concentrations in association with Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2000; 12: 497-503.
16. Davies GR, Simmonds NJ, Stevens TR et.al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35: 179-85.
17. Xia HH, Wong BC. Nitric oxide in Helicobacter pylori-induced apoptosis and its significance in gastric carcinogenesis. J Gastroenterol Hepatol 2003; 18: 1227-30.
18. Xia HH. Association between Helicobacter pylori and gastric cancer: current knowledge and future research. World J Gastroenterol 1998; 4: 93-6.
19. Jones NL, Shannon PT, Cutz E, Yeger H, Sherman PM. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151: 1695-703.
20. Cahill RJ, Xia H, Kilgallen C, Beattie S, Hamilton H, O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci 1995; 40: 1627-31.
21. Moss SF, Calam J, Agarwal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
22. Yang Y, Deng CS, Peng JZ, Wong BC, Lam SK, Xia HH. Effect of Helicobacter pylori on apoptosis and apoptosis related genes in gastric cancer cells. Mol Pathol 2003; 56: 19-24.
23. Fuccio L, Zagari RM, Minardi ME, Bazzoli F. Systematic review. Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007; 25: 133-41.
24. Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res 2001; 61: 2847-51.
25. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 281-9.
26. Witteman EM, Mravunac M, Becx MJ et.al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 1995; 48: 250-6.
27. Forbes GM, Warren JR, Glaser ME, Cullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J Gastroenterol Hepatol 1996; 11: 670-3.
28. Ciok J, Dzieniszewski J, Lucer C. Helicobacter pylori eradication and antral intestinal metaplasia - two years follow-up study. J Physiol Pharmacol 1997; 48 (Suppl. 4): 115-22.
29. van der Hulst RW, van der Ende A, Dekker FW et.al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: A prospective 1-year follow-up study. Gastroenterology 1997; 113: 25-30.
30. Uemura N, Mukai T, Okamoto S et.al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42.
31. Tucci A, Poli L, Tosetti C et.al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-31.
32. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998; 3: 236-40.
33. Tepes B, Kavcic B, Zaletel LK et.al. Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J Pathol 1999; 188: 24-9.
34. Kyzekova J, Mour J. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology 1999; 46: 2048-56.
35. Annibale B, Aprile MR, D'Ambra G, Caruana P, Bordi C, Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment Pharmacol Ther 2000; 14: 625-34.
36. Sung JJ, Lin SR, Ching JY et.al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: A prospective, randomized study. Gastroenterology 2000; 119: 7-14.
37. Correa P, Fontham ET, Bravo JC et.al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti- helicobacter pylori therapy. J Natl Cancer Inst 2000; 92: 1881-8.
38. Kim N, Lim SH, Lee KH et.al. Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers. Dig Dis Sci 2000; 45: 1754-62.
39. Hsu PI, Lai KH, Tseng HH et.al. Impact of Helicobacter pylori eradication on the development of MALT, gland atrophy and intestinal metaplasia of the antrum. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63: 279-87.
40. Ohkusa T, Fujiki K, Takashimizu I et.al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann Intern Med 2001; 134: 380-6.
41. Ruiz B, Garay J, Correa P et.al. Morphometric evaluation of gastric antral atrophy: Improvement after cure of Helicobacter pylori infection. Am J Gastroenterol 2001; 96: 3281-7.
42. Kokkola A, Sipponen P, Rautelin H et.al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther 2002; 16: 515-20.
43. Ito M, Haruma K, Kamada T et.al. Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: A 5-year prospective study of patients with atrophic gastritis. Aliment Pharmacol Ther 2002; 16: 1449-56.
44. Zhou L, Sung JJ, Lin S et.al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J (Engl) 2003; 116: 11-4.
45. Kamada T, Haruma K, Hata J et.al. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther 2003; 18: 245-52.
46. Leung WK, Lin SR, Ching JY et.al. Factors predicting progression of gastric intestinal metaplasia. results of a randomised trial on Helicobacter pylori eradication. Gut 2004; 53: 1244-9.
47. Ley C, Mohar A, Guarner J et.al. Helicobacter pylori eradication and gastric preneoplastic conditions: A randomized, double-blind, placebo-controlled trial. Cancer Epidemiol Biomarkers Prev 2004; 13: 4-10.
48. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC et.al. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: Results of a randomised controlled trial. Gut 2004; 53: 12-20.
49. Mera R, Fontham ET, Bravo LE et.al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-40.
50. You WC, Brown LM, Zhang L et.al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst 2006; 98: 974-83.
51. Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001; 49: 2-4.
52. Wong BC, Lam SK, Wong WM et.al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: A randomized controlled trial. JAMA 2004; 291: 187-94.
53. Take S, Mizuno M, Ishiki K et.al. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease. Am J Gastroenterol 2005; 100: 1037-42.
54. Nozaki K, Shimizu N, Ikehara Y et.al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003; 94: 235-9.
55. Cai X, Carlson J, Stoicov C, Li H, Wang TC, Houghton J. Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 2005; 128: 1937-52.
56. Xia HH, Yu Wong BC, Talley NJ, Lam SK. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opin Pharmacother 2002; 3: 1301-11.
57. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials. Lancet 1996; 348: 150-4.
58. Fendrick AM, Chernew ME, Hirth RA, Bloom BS, Bandekar RR, Scheiman JM. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159: 142-8.
59. Roderick P, Davies R, Raftery J et.al. Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. J Med Screen 2003; 10: 148-56.
60. Michetti P, Svennerholm AM. Helicobacter pylori-inflammation, immunity and vaccines. Helicobacter 2003; 8 (Suppl. 1): 31-5.